Bright Minds Biosciences Stock Analysis

DRUG Stock  USD 44.00  4.82  12.30%   
Bright Minds Biosciences is overvalued with Real Value of 17.41 and Target Price of 4.87. The main objective of Bright Minds stock analysis is to determine its intrinsic value, which is an estimate of what Bright Minds Biosciences is worth, separate from its market price. There are two main types of Bright Minds' stock analysis: fundamental analysis and technical analysis.
The Bright Minds stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Bright Minds' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Bright Stock Analysis Notes

About 27.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.63. Bright Minds Biosciences had not issued any dividends in recent years. The entity had 1:5 split on the 14th of July 2023. Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT medicines to improve the lives of patients with severe and life-altering diseases. The company was incorporated in 2019 and is headquartered in Vancouver, Canada. Bright Minds is traded on NASDAQ Exchange in the United States. To learn more about Bright Minds Biosciences call Ian McDonald at 647 407 2515 or check out https://brightmindsbio.com.

Bright Minds Biosciences Investment Alerts

Bright Minds is way too risky over 90 days horizon
Bright Minds appears to be risky and price may revert if volatility continues
Bright Minds has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (7.37 M) with profit before overhead, payroll, taxes, and interest of 0.
Bright Minds Biosciences currently holds about 8.64 M in cash with (7.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71.
Bright Minds has a frail financial position based on the latest SEC disclosures
Roughly 27.0% of the company shares are held by company insiders
Latest headline from investing.com: Baird assigns Outperform to Bright Minds stock, sees positive readthrough from recent MA

Bright Minds Biosciences Upcoming and Recent Events

6th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Bright Minds Environmental, Social, and Governance (ESG) Scores

Bright Minds' ESG score is a quantitative measure that evaluates Bright Minds' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Bright Minds' operations that may have significant financial implications and affect Bright Minds' stock price as well as guide investors towards more socially responsible investments.

Bright Minds Thematic Classifications

In addition to having Bright Minds stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products Idea
Pharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

Bright Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Advisorshares Investments, Llc2024-09-30
182.4 K
Jane Street Group Llc2024-06-30
10.9 K
Royal Bank Of Canada2024-06-30
510
Aspire Private Capital, Llc2024-09-30
100.0
Blackrock Inc2024-06-30
1.0
Note, although Bright Minds' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Bright Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 268.26 M.

Bright Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(1.23)(1.29)
Return On Capital Employed(1.28)(1.35)
Return On Assets(1.23)(1.29)
Return On Equity(1.28)(1.35)

Management Efficiency

Bright Minds Biosciences has return on total asset (ROA) of (0.2886) % which means that it has lost $0.2886 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.518) %, meaning that it created substantial loss on money invested by shareholders. Bright Minds' management efficiency ratios could be used to measure how well Bright Minds manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.29. The current Return On Capital Employed is estimated to decrease to -1.35. At this time, Bright Minds' Other Current Assets are most likely to increase significantly in the upcoming years.
Last ReportedProjected for Next Year
Book Value Per Share 1.60  2.80 
Tangible Book Value Per Share 1.60  2.80 
Enterprise Value Over EBITDA(0.16)(0.17)
Price Book Value Ratio 1.39  1.32 
Enterprise Value Multiple(0.16)(0.17)
Price Fair Value 1.39  1.32 
Enterprise Value10.9 M10.4 M
Bright Minds Biosciences benefits from a management team that prioritizes both innovation and efficiency. We analyze these priorities to gauge the stock's future performance.
Beta
1.132
Return On Assets
(0.29)
Return On Equity
(0.52)

Technical Drivers

As of the 30th of November, Bright Minds shows the Downside Deviation of 8.29, mean deviation of 49.07, and Risk Adjusted Performance of 0.1163. Bright Minds Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bright Minds Biosciences information ratio, as well as the relationship between the potential upside and kurtosis to decide if Bright Minds Biosciences is priced correctly, providing market reflects its regular price of 44.0 per share. Given that Bright Minds has jensen alpha of 29.0, we suggest you to validate Bright Minds Biosciences's prevailing market performance to make sure the company can sustain itself at a future point.

Bright Minds Biosciences Price Movement Analysis

Execute Study
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Bright Minds middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Bright Minds Biosciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Bright Minds Biosciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bright Minds insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bright Minds' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bright Minds insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Cormorant Asset Management, Lp over three weeks ago
Acquisition by Cormorant Asset Management, Lp of 184331 shares of Bright Minds at 21.7 subject to Rule 16b-3
 
Cormorant Asset Management, Lp over a month ago
Insider Trading

Bright Minds Outstanding Bonds

Bright Minds issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bright Minds Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bright bonds can be classified according to their maturity, which is the date when Bright Minds Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Bright Minds Predictive Daily Indicators

Bright Minds intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bright Minds stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Bright Minds Corporate Filings

6K
21st of November 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
19th of November 2024
Other Reports
ViewVerify
13A
12th of November 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
13A
6th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
6K
5th of November 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
13A
25th of October 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
13A
23rd of October 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
22nd of October 2024
Other Reports
ViewVerify

Bright Minds Forecast Models

Bright Minds' time-series forecasting models are one of many Bright Minds' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bright Minds' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Bright Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bright Minds prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bright shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bright Minds. By using and applying Bright Stock analysis, traders can create a robust methodology for identifying Bright entry and exit points for their positions.
Last ReportedProjected for Next Year

Current Bright Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bright analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bright analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
4.87Strong Sell0Odds
Bright Minds Biosciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Bright analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Bright stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Bright Minds Biosciences, talking to its executives and customers, or listening to Bright conference calls.
Bright Analyst Advice Details

Bright Stock Analysis Indicators

Bright Minds Biosciences stock analysis indicators help investors evaluate how Bright Minds stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bright Minds shares will generate the highest return on investment. By understating and applying Bright Minds stock analysis, traders can identify Bright Minds position entry and exit signals to maximize returns.
Begin Period Cash Flow11.6 M
Common Stock Shares Outstanding3.7 M
Total Stockholder Equity6.6 M
Property Plant And Equipment Net66.4 K
Cash And Short Term Investments6.7 M
Cash6.7 M
Accounts Payable182.3 K
Net Debt-6.7 M
50 Day M A28.6102
Total Current Liabilities280.9 K
Other Operating Expenses7.2 M
Non Current Assets Total66.4 K
Stock Based Compensation1.2 M

Complementary Tools for Bright Stock analysis

When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stocks Directory
Find actively traded stocks across global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges